UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
83.77 +0.96 (+1.16%) GOLD FUTURES
2,344.60 +6.20 (+0.27%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,911.71 +687.64 (+1.34%)
Kura Oncology, Inc. (KURA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 18.75 |
| Open | 18.26 |
| Bid | 18.98 x 200 |
| Ask | 19.05 x 200 |
| Day's range | 17.96 - 19.22 |
| 52-week range | 7.41 - 24.17 |
| Volume | |
| Avg. volume | 1,159,187 |
| Market cap | 1.447B |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript February 27, 2024 Kura Oncology, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.56. Kura Oncology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
- Thomson Reuters StreetEvents
Q4 2023 Kura Oncology Inc Earnings Call
Q4 2023 Kura Oncology Inc Earnings Call
- GuruFocus.com
Kura Oncology Inc (KURA) Reports Q4 and Full Year 2023 Financial Results
Advancements in AML Treatments and Strong Cash Position Highlighted
© 2024 Yahoo. All rights reserved.